Related references
Note: Only part of the references are listed.COX-2 and Prostaglandin EP3/EP4 Signaling Regulate the Tumor Stromal Proangiogenic Microenvironment via CXCL12-CXCR4 Chemokine Systems
Hiroshi Katoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma
Thorbjorn Krejsgaard et al.
BLOOD (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
Selective Cyclooxygenase-2 (COX-2) Inhibitors Used for Preventing or Regressing Cancer
Ricardo de Souza Pereira
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2009)
Celecoxib transiently inhibits cellular protein synthesis
Peter Pyrko et al.
BIOCHEMICAL PHARMACOLOGY (2008)
PGE2 induces COX-2 expression in podocytes via the EP4 receptor through a PKA-independent mechanism
Wissam H. Faour et al.
CELLULAR SIGNALLING (2008)
Targeting cyclooxygenase-2 in hematological malignancies: Rationale and promise
M. P. Bernard et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
Anders Woetmann et al.
BLOOD (2007)
Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL)
L. Karenko et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
A Sors et al.
BLOOD (2006)
Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line
S Arico et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
